(Q36853927)

16 August 2017

Early-phase development of cancer prevention agents: challenges and opportunities (English)

1 reference

16 August 2017

Marjorie Perloff

1

1 reference

PMC publication ID

3657502

16 August 2017

Vernon E Steele

series ordinal

2

1 reference

16 August 2017

6 March 2013

1 reference

Cancer Prevention Research

16 August 2017

1 reference

16 August 2017

6

1 reference

16 August 2017

5

1 reference

16 August 2017

379-383

1 reference

Phase 0 clinical chemoprevention trial of the Akt inhibitor SR13668

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657502

Phase 0 trials: expediting the development of chemoprevention agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657502

Development of dietary phytochemical chemopreventive agents: biomarkers and choice of dose for early clinical trials.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657502

Phase 0 clinical trial of the poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657502

Phase 0 trials: an industry perspective

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657502

Designing phase 0 cancer clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657502

Comprehensive review of cancer chemopreventive agents evaluated in experimental carcinogenesis models and clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657502

Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657502

Phase 0 clinical trials: an answer to drug development stagnation?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657502

Early microdose drug studies in human volunteers can minimise animal testing: Proceedings of a workshop organised by Volunteers in Research and Testing

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657502

10.1158/1940-6207.CAPR-12-0463

4 September 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

PMC publication ID

3657502

16 August 2017

PubMed publication ID

23466485

1 reference

PMC publication ID

3657502